Parkinson’s News Forums › Forums › Parkinson’s Research › Nilotinib Has Potential to Modulate Dopamine in People with Parkinson’s

  • Parkinson’s Research

    Nilotinib Has Potential to Modulate Dopamine in People with Parkinson’s

    Posted by Forum Moderator on August 28, 2018 at 8:12 am

    A recent study indicates that Novartis’ anti-leukemia agent Nilotinib can modulate dopamine levels and potentially promote long-term benefits to Parkinson’s patients. Read more here.

    What do you think about this news?

    replied 5 years, 8 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .